Quick Answer
COSCIENS Biopharma Inc. reported Gross Profit of $2.65 million for fiscal year 2025.
COSCIENS Biopharma Inc. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $2.65M | -44.0% |
| 2024 | $4.73M | +61.0% |
| 2023 | $2.94M | -73.3% |
| 2022 | $11.02M | -55.5% |
| 2018 | $24.78M | +2584.4% |
| 2017 | $923.0K | +1.3% |
| 2016 | $911.0K | — |
- COSCIENS Biopharma Inc. showed a decrease of -44.0% in Gross Profit compared to the prior fiscal year.
- Over the 2016–2025 period, COSCIENS Biopharma Inc.’s gross profit has grown by 190.6% (from $911.0 thousand to $2.65 million).
- The most recent figure is from COSCIENS Biopharma Inc.’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: